State-of-the-Art Sedation: An Interactive Case-Study Discussion

Pharmacists and Pharmacy Techs: New CE Requirements. Click here for more info.

- Multimedia -

Activity Description

The combined use of sedatives and analgesics in critically ill adults is key to optimizing patient comfort and safety. But it is unquestionably challenging for critical care practitioners -- a balance of science and art. Without agreed-upon target levels of sedation, different members of the healthcare team may have disparate treatment goals, thereby increasing the likelihood of iatrogenic complications and potentially impeding recovery. An interdisciplinary ABCDE bundle of care is a strategy for bringing the best of critical care research to the bedside. The components of this bundle are: AB, the combined use of Awakening (daily sedation cessation) and Breathing trials; C, Choice of sedative; D, Delirium screening and management; and E, Early exercise. This activity uses a case-study format to review and discuss the ABCDE bundle of care. It is designed to enhance multidisciplinary collaboration in the provision of state-of-the-art sedation for critically ill patients.

Learning Objectives

Upon completion of this activity, participants will be able to:

Describe the valid and reliable delirium assessment tools recommended for use in the ICU
List the components of an early exercise and mobility protocol in the ICU
Identify common barriers to implementation of daily sedation cessation

Faculty

Brenda T. Pun, RN, MSN, ACNP
Program Clinical Manager
Vanderbilt University Medical Center
Nashville, Tennessee

John W. Devlin, PharmD, BCPS, FCCM, FCCP
Associate Professor, Department of Pharmacy Practice
Northeastern University
Boston, Massachusetts

Curtis N. Sessler, MD, FCCP, FCCM
Orhan Muren Professor of Medicine
Director, Center for Adult Critical Care
Virginia Commonwealth University Health System
Richmond, Virginia

Disclosure

It is the policy of ProCE, Inc. to ensure balance, independence, objectivity and scientific rigor in all of its continuing education activities. Faculty must disclose to participants the existence of any significant financial interest or any other relationship with the manufacturer of any commercial product(s) discussed in an educational presentation. Ms. Brenda Pun reports having received honorarium from Hospira, Inc. Dr. John Devlin reports having received research grants from Hospira, Inc. Dr. Curtis Sessler reports having received honorarium from Hospira, Inc.

Please note: The opinions expressed in this activity should not be construed as those of the CME/CE provider. The information and views are those of the faculty through clinical practice and knowledge of the professional literature. Portions of this activity may include the use of drugs for unlabeled indications. Use of drugs outside of labeling should be considered experimental and participants are advised to consult prescribing information and professional literature.

CE Accreditation

Release Date: 07-15-2011

Expiration Date: 07-15-2013

Nurses
This educational offering has been approved for 1.0 contact hour of continuing nursing education credit (Synergy CERP Category A for CCRN renewal) by the American Association of Critical-Care Nurses (AACN). Documentation records are kept on file at AACN.

The American Association of Critical-Care Nurses (AACN) is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center's Commission on Accreditation.

AACN has been approved as a provider of continuing education in nursing by the State Boards of Nursing of Alabama (#ABNP0062), California (#01036), and Louisiana (#ABN12). AACN programming meets the standards for most other states requiring mandatory continuing education credit for relicensure.

Pharmacists
ProCE, Inc. is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. ACPE Universal Activity Number 221-999-11-024-H01-P has been assigned to this knowledge-based home-study CE activity (initial release date 07-15-11). This activity is approved for 1.0 contact hour (0.1 CEU) in states that recognize ACPE providers. The activity is provided at no cost to participants. Statements of credit will be issued online upon completion of the activity evaluation and the post-test with a score of 70% or higher. No partial credit will be given.

Physicians
This activity has been planned and implemented in accordance with the essential Areas and Policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint sponsorship of ProCE, Inc. and the National Association of Managed Care Physicians (NAMCP). The NAMCP is accredited by the ACCME to provide continuing medical education (CME) to physicians. The NAMCP designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should only claim credit commensurate with the extent of their participation in the activity.

Funding

This activity is provided by AACN and ProCE, and is supported by an educational grant from Hospira, Inc.

To Participate

To participate in this Web-based continuing education activity:
1.	Review the activity description and objectives.
2.	View the activity by clicking on the link below.
3.	Take the online post-test and complete the evaluation by clicking the appropriate link below (i.e. nurse, pharmacist, or physician); registration will be required.

View this Activity

View Activity

Post-Test / Evaluation and CE Statement

To take the post-test, complete the evaluation, and to obtain your CE/CME statement:

Nurses Only

Click here for Nurse Post-Test

Pharmacists & Physicians Only

New User
Click here to register
Existing User / Not Yet Enrolled in this Course
Click here to enroll
(previous ProCE user that has NOT yet enrolled in this specific course)
Existing User / Already Enrolled in the Course
Click here
(To resume taking the post-test OR Reprint CE Statement)

The material presented in this CE activity does not reflect the views of ProCE, Inc. or the commercial sponsor. These materials may discuss uses and dosages for therapeutic products, processes, procedures and inferred diagnoses that have not been approved by the United States Food and Drug Administration. A qualified health care professional should be consulted before using any therapeutic product discussed. All readers and continuing education participants should verify all information and data before treating patients or employing any therapies described in this continuing education activity.

Click here for ProCE, Inc.'s Privacy Policy.